Learn more

SHENZHEN SCIPROGEN BIO PHARMACEUTICAL CO LTD

Overview
  • Total Patents
    11
  • GoodIP Patent Rank
    212,411
About

SHENZHEN SCIPROGEN BIO PHARMACEUTICAL CO LTD has a total of 11 patent applications. Its first patent ever was published in 2009. It filed its patents most often in China, Hong Kong and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology are TANUMA YASUKAZU, NAKAJIMA KUNIO and OSAKA BIO SCI KENKYUSHO.

Patent filings in countries

World map showing SHENZHEN SCIPROGEN BIO PHARMACEUTICAL CO LTDs patent filings in countries

Patent filings per year

Chart showing SHENZHEN SCIPROGEN BIO PHARMACEUTICAL CO LTDs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Biotechnology

Focus technologies

# Technology
#1 Peptides

Top inventors

# Name Total Patents
#1 Sheng Guangyang 7
#2 Zhang Diping 7
#3 Wu Yuanyuan 7
#4 Chen Xianguang 4
#5 Zhang Xiangrong 4
#6 Li Xionghui 3
#7 Huang Jian 3
#8 Wang Kang 3
#9 Huang Junlong 3
#10 Zheng Huagan 3

Latest patents

Publication Filing date Title
CN104804110A High-purity nadroparin calcium
CN104007079A Spectral detection method for recombinant human erythropoietin PEGylation reaction liquid and application thereof
CN103820514A Method for efficiently producing EPO (erythropoietin)
CN103204958A Production process of nadroparin calcium with low ethanol residue
CN103149170A Solution concentration of nadroparin calcium determined by phenanthroline-zinc sulfate ultraviolet spectroscopy
CN102816227A Erythropoietin recovery method
CN102746405A Continuous pegylation reaction method for recombinant human erythropoietin (EPO)
CN102268402B Serum free medium and culture method for high expression of erythropoietin in CHO (Chinese hamster ovary) cells
CN102178654A Sustained-release microspheres and preparation method thereof
HK1127615A1 Polymer/ recombinant human erythropoietin conjugate